Oualid Talhi
AuthID: R-001-STY
1
TITLE: Multicomponent synthesis of pyranonicotinonitrile and chromene-3-carbonitrile: Studies on bioactivities and molecular docking
AUTHORS: Siziani, Dhaouya; Ziani, Borhane Eddine Cherif; Abdi, Yamina; Bensouilah, Nadjia; Boutemeur Kheddis, Baya; Ziani, Chaima; Boukkena, Leila; Hamdi, Maamar; Talhi, Oualid; Bachari, Khaldoun; Silva, Artur M. S.;
PUBLISHED: 2022, SOURCE: JOURNAL OF MOLECULAR STRUCTURE, VOLUME: 1263, ISSUE: 1
AUTHORS: Siziani, Dhaouya; Ziani, Borhane Eddine Cherif; Abdi, Yamina; Bensouilah, Nadjia; Boutemeur Kheddis, Baya; Ziani, Chaima; Boukkena, Leila; Hamdi, Maamar; Talhi, Oualid; Bachari, Khaldoun; Silva, Artur M. S.;
PUBLISHED: 2022, SOURCE: JOURNAL OF MOLECULAR STRUCTURE, VOLUME: 1263, ISSUE: 1
2
TITLE: Molecular docking and dynamic studies of a potential therapeutic target inhibiting glyoxalase system: Metabolic action of the 3, 3 '- [3-(5-chloro-2-hydroxyphenyl)-3-oxopropane-1, 1-diyl]- Bis-4-hydroxycoumarin leads overexpression of the intracellular level of methylglyoxal and induction of a pro-apoptotic phenomenon in a hepatocellular carcinoma model Full Text
AUTHORS: Taibi, N; Al balas, QA; Bekari, N; Talhi, O; Al Jabal, GA; Benali, Y; Ameraoui, R; Hadjadj, M; Taibi, A; Boutaiba, ZM; Abou Mustapha, M; Khammar, F; Dergal, F; Hassaine, R; Boukenna, L; Bachari, K; Silva, AMS ;
PUBLISHED: 2021, SOURCE: CHEMICO-BIOLOGICAL INTERACTIONS, VOLUME: 345
AUTHORS: Taibi, N; Al balas, QA; Bekari, N; Talhi, O; Al Jabal, GA; Benali, Y; Ameraoui, R; Hadjadj, M; Taibi, A; Boutaiba, ZM; Abou Mustapha, M; Khammar, F; Dergal, F; Hassaine, R; Boukenna, L; Bachari, K; Silva, AMS ;
PUBLISHED: 2021, SOURCE: CHEMICO-BIOLOGICAL INTERACTIONS, VOLUME: 345
INDEXED IN: 
WOS
WOS3
TITLE: Hemi-Synthesis of Chiral Imine, Benzimidazole and Benzodiazepines from Essential Oil of Ammodaucus leucotrichus subsp. leucotrichus Full Text
AUTHORS: Chebrouk, F; Madani, K; Cherfaoui, B; Boukenna, L; Valega, M; Mendes, RF; Paz, FAA; Bachari, K; Talhi, O; Silva, AMS ;
PUBLISHED: 2019, SOURCE: MOLECULES, VOLUME: 24, ISSUE: 5
AUTHORS: Chebrouk, F; Madani, K; Cherfaoui, B; Boukenna, L; Valega, M; Mendes, RF; Paz, FAA; Bachari, K; Talhi, O; Silva, AMS ;
PUBLISHED: 2019, SOURCE: MOLECULES, VOLUME: 24, ISSUE: 5
4
TITLE: Synthesis of Benzophenones and in vitro Evaluation of Their Anticancer Potential in Breast and Prostate Cancer Cells Full Text
AUTHORS: Saidi, L; Rocha, DHA; Talhi, O; Bentarzi, Y; Nedjar Kolli, B; Bachari, K; Paz, FAA; Helguero, LA; Silva, AMS ;
PUBLISHED: 2019, SOURCE: CHEMMEDCHEM, VOLUME: 14, ISSUE: 10
AUTHORS: Saidi, L; Rocha, DHA; Talhi, O; Bentarzi, Y; Nedjar Kolli, B; Bachari, K; Paz, FAA; Helguero, LA; Silva, AMS ;
PUBLISHED: 2019, SOURCE: CHEMMEDCHEM, VOLUME: 14, ISSUE: 10
5
TITLE: Bis(4-hydroxy-2H-chromen-2-one) Coumarin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Aromatase Inhibition
AUTHORS: Lamia Hamdan Ramdani; Oualid Talhi; Caroline Decombat; Marion Vermerie; Alexandre Berry; Artur Silva; Khaldoun Bachari; Marie Paule Vasson; Laetitia Delort; Florence Caldefie Chezet;
PUBLISHED: 2019, SOURCE: ANTICANCER RESEARCH, VOLUME: 39, ISSUE: 11
AUTHORS: Lamia Hamdan Ramdani; Oualid Talhi; Caroline Decombat; Marion Vermerie; Alexandre Berry; Artur Silva; Khaldoun Bachari; Marie Paule Vasson; Laetitia Delort; Florence Caldefie Chezet;
PUBLISHED: 2019, SOURCE: ANTICANCER RESEARCH, VOLUME: 39, ISSUE: 11
INDEXED IN: 
Scopus WOS
Scopus WOS6
TITLE: Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer
AUTHORS: Lee, JY; Talhi, O; Jang, DM; Cerella, C; Gaigneaux, A; Kim, KW; Lee, JW; Dicato, M; Bachari, K; Han, BW; Silva, AMS ; Orlikova, B; Diederich, M;
PUBLISHED: 2018, SOURCE: CANCER LETTERS, VOLUME: 416
AUTHORS: Lee, JY; Talhi, O; Jang, DM; Cerella, C; Gaigneaux, A; Kim, KW; Lee, JW; Dicato, M; Bachari, K; Han, BW; Silva, AMS ; Orlikova, B; Diederich, M;
PUBLISHED: 2018, SOURCE: CANCER LETTERS, VOLUME: 416
7
TITLE: Diastereoselective One-Pot Tandem Synthesis of Chromenopyridodiazepinones through 1,4-and 1,6-Aza-Conjugate Additions/Heterocyclizations
AUTHORS: Bouchama, A; Hassaine, R; Talhi, O; Taibi, N; Mendes, RF; Paz, FAA; Bachari, K; Silva, AMS ;
PUBLISHED: 2018, SOURCE: SYNLETT, VOLUME: 29, ISSUE: 7
AUTHORS: Bouchama, A; Hassaine, R; Talhi, O; Taibi, N; Mendes, RF; Paz, FAA; Bachari, K; Silva, AMS ;
PUBLISHED: 2018, SOURCE: SYNLETT, VOLUME: 29, ISSUE: 7
8
TITLE: Cholinesterase Inhibitory Activity of Some Semi-rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site
AUTHORS: Ben Hadda, T; Talhi, O; Silva, ASM; Senol, FS; Orhan, IE; Rauf, A; Mabkhot, YN; Bachari, K; Warad, I; Farghaly, TA; Althagafi, II; Mubarak, MS;
PUBLISHED: 2018, SOURCE: MINI-REVIEWS IN MEDICINAL CHEMISTRY, VOLUME: 18, ISSUE: 8
AUTHORS: Ben Hadda, T; Talhi, O; Silva, ASM; Senol, FS; Orhan, IE; Rauf, A; Mabkhot, YN; Bachari, K; Warad, I; Farghaly, TA; Althagafi, II; Mubarak, MS;
PUBLISHED: 2018, SOURCE: MINI-REVIEWS IN MEDICINAL CHEMISTRY, VOLUME: 18, ISSUE: 8
9
TITLE: One-Pot Three-Component Synthesis of Bispyrazole-thiazole-pyran-2-one Heterocyclic Hybrids
AUTHORS: Saidoun, A; Boukenna, L; Rachedi, Y; Talhi, O; Laichi, Y; Lemouari, N; Trari, M; Bachari, K; Silva, AMS ;
PUBLISHED: 2018, SOURCE: SYNLETT, VOLUME: 29, ISSUE: 13
AUTHORS: Saidoun, A; Boukenna, L; Rachedi, Y; Talhi, O; Laichi, Y; Lemouari, N; Trari, M; Bachari, K; Silva, AMS ;
PUBLISHED: 2018, SOURCE: SYNLETT, VOLUME: 29, ISSUE: 13
10
TITLE: Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release
AUTHORS: Mazumder, A; Lee, JY; Talhi, O; Cerella, C; Chateauvieux, S; Gaigneaux, A; Hong, CR; Kang, HJ; Lee, Y; Kim, KW; Kim, DW; Shin, HY; Dicato, M; Bachari, K; Silva, AMS ; Orlikova Boyer, B; Diederich, M;
PUBLISHED: 2018, SOURCE: CANCER LETTERS, VOLUME: 438
AUTHORS: Mazumder, A; Lee, JY; Talhi, O; Cerella, C; Chateauvieux, S; Gaigneaux, A; Hong, CR; Kang, HJ; Lee, Y; Kim, KW; Kim, DW; Shin, HY; Dicato, M; Bachari, K; Silva, AMS ; Orlikova Boyer, B; Diederich, M;
PUBLISHED: 2018, SOURCE: CANCER LETTERS, VOLUME: 438
